\-\ Texto\\:\\ \ \(0\)\
\-\ hct\\:\\ 32\ \(0\)\
\-\ initial\\ upper\\ endoscopy\\:\\ \\ negative\ \(0\)\
\-\ colonoscopy\\:\\ \\ negative\ \(0\)\
\-\ endoscopy\\ offers\\ not\\ only\\ diagnostic\\ ability\\,\\ but\\ also\\ therapeutic\\ options\\ for\\ upper\\ gi\\ bleeding\\.\ \(0\)\
\-\ abc\\'s\\ and\\ patient\\ stabilization\\ always\\ first\\ priority\\.\\ \\ endoscopic\\ techniques\\ include\\ injection\\ therapy\\,\\ electrocoagulation\\,\\ heat\\ probes\\ and\\ laser\\ rx\\.\ \(0\)\
\-\ interventionaly\\ angiography\\ could\\ also\\ benefit\\ in\\ difficult\\ patients\\.\\ \\ surgery\\ is\\ last\\ resort\\.\ \(0\)\
\-\ additional\\ medical\\ rx\\ includes\\:\\ h\\.pylori\\ treatment\\ \\(if\\ \\+\\)\\ and\\ acid\\ reducing\\ medicines\\.\ \(0\)\
\-\ nuclear\\ medicine\\ gi\\ bleeding\\ scan\\:\\ \\ focus\\ of\\ increasing\\ radiotracer\\ activity\\ at\\ the\\ duodenal\\ region\\ which\\ conforms\\ to\\ bowel\\ and\\ moves\\ antegrade\\.\ \(0\)\
\-\ endoscopy\\:\\ \\ duodenal\\ ulcer\ \(0\)\
\-\ duodenal\\ ulcer\ \(21\)\
\-\ differential\\ diagnosis\\ \\(based\\ on\\ nuc\\ med\\ rbc\\ scan\\)\\:\ \(0\)\
\-\ 1\\)peptic\\ ulcer\\ disease\ \(0\)\
\-\ 2\\)duodenitis\\-much\\ less\\ likely\ \(0\)\
\-\ 3\\)douodenal\\ neoplasm\\-much\\ less\\ likely\ \(0\)\
\-\ 47\\ y\\/o\\ male\\ with\\ fatigue\\ and\\ weakness\\.\ \(1\)\
\-\ this\\ case\\ was\\ unusual\\ in\\ that\\ the\\ initial\\ upper\\ endoscopy\\ was\\ negative\\.\\ \\ considerations\\ thought\\ to\\ include\\:\\ nonactive\\ bleeding\\ at\\ time\\ of\\ endoscopy\\,\\ redundant\\ duodenal\\ mucosal\\ which\\ obscured\\ ulcer\\,\\ or\\ suboptimal\\ evaluation\\ of\\ duodenal\\ region\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ endoscopy\\:\\ 0\\.13509063970105484\ \(0\)\
\-\ duodenal\\:\\ 0\\.12766075676434332\ \(0\)\
\-\ ulcer\\:\\ 0\\.10283376086979644\ \(0\)\
\-\ rx\\:\\ 0\\.06918701392544806\ \(0\)\
\-\ bleeding\\:\\ 0\\.06081267131255603\ \(0\)\
\-\ \\:\\:\\ 0\\.0494109209176247\ \(0\)\
\-\ probes\\:\\ 0\\.048172231824953546\ \(0\)\
\-\ interventionaly\\:\\ 0\\.048172231824953546\ \(0\)\
\-\ conforms\\:\\ 0\\.048172231824953546\ \(0\)\
\-\ duodenitis\\-much\\:\\ 0\\.048172231824953546\ \(0\)\
\-\ douodenal\\:\\ 0\\.048172231824953546\ \(0\)\
\-\ neoplasm\\-much\\:\\ 0\\.048172231824953546\ \(0\)\
\-\ nonactive\\:\\ 0\\.048172231824953546\ \(0\)\
\-\ electrocoagulation\\:\\ 0\\.04438454231369701\ \(0\)\
\-\ h\\.pylori\\:\\ 0\\.04438454231369701\ \(0\)\
\-\ gi\\:\\ 0\\.04195393094585709\ \(0\)\
\-\ negative\\:\\ 0\\.04183803543237499\ \(0\)\
\-\ priority\\:\\ 0\\.04059685280244048\ \(0\)\
\-\ medicines\\:\\ 0\\.04059685280244048\ \(0\)\
\-\ nuc\\:\\ 0\\.04059685280244048\ \(0\)\
\-\ resort\\:\\ 0\\.039377489134056816\ \(0\)\
\-\ offers\\:\\ 0\\.03838119647398056\ \(0\)\
\-\ redundant\\:\\ 0\\.03558979962280029\ \(0\)\
\-\ suboptimal\\:\\ 0\\.035068978968131846\ \(0\)\
\-\ reducing\\:\\ 0\\.03415611511751345\ \(0\)\
\-\ antegrade\\:\\ 0\\.03415611511751345\ \(0\)\
\-\ upper\\:\\ 0\\.03380459844866752\ \(0\)\
\-\ abc\\:\\ 0\\.033751153521045026\ \(0\)\
\-\ laser\\:\\ 0\\.03302147377992742\ \(0\)\
\-\ obscured\\:\\ 0\\.032082401337705235\ \(0\)\
\-\ less\\:\\ 0\\.03162775961008396\ \(0\)\
\-\ peptic\\:\\ 0\\.03153549719258511\ \(0\)\
\-\ initial\\:\\ 0\\.030946252932014296\ \(0\)\
\-\ moves\\:\\ 0\\.030805817451467498\ \(0\)\
\-\ stabilization\\:\\ 0\\.030162194305804205\ \(0\)\
\-\ heat\\:\\ 0\\.029233784268670883\ \(0\)\
\-\ ability\\:\\ 0\\.02844043995258073\ \(0\)\
\-\ techniques\\:\\ 0\\.02787948829105022\ \(0\)\
\-\ benefit\\:\\ 0\\.02787948829105022\ \(0\)\
\-\ endoscopic\\:\\ 0\\.02749359994561878\ \(0\)\
\-\ acid\\:\\ 0\\.027370797454623928\ \(0\)\
\-\ colonoscopy\\:\\ 0\\.027250694139220783\ \(0\)\
\-\ rbc\\:\\ 0\\.02690545423964957\ \(0\)\
\-\ considerations\\:\\ 0\\.02690545423964957\ \(0\)\
\-\ med\\:\\ 0\\.026795056931903562\ \(0\)\
\-\ region\\:\\ 0\\.026378155488954235\ \(0\)\
\-\ likely\\:\\ 0\\.026341966840826847\ \(0\)\
\-\ therapeutic\\:\\ 0\\.02627423627723512\ \(0\)\
\-\ include\\:\\ 0\\.026198398776287286\ \(0\)\
\-\ scan\\:\\ 0\\.02614504328342053\ \(0\)\
\-\ hct\\:\\ 0\\.025361372426616725\ \(0\)\
\-\ fatigue\\:\\ 0\\.0249564108301483\ \(0\)\
\-\ 47\\:\\ 0\\.02450702231519217\ \(0\)\
\-\ \\+\\:\\ 0\\.02409179877979369\ \(0\)\
\-\ nuclear\\:\\ 0\\.02409179877979369\ \(0\)\
\-\ mucosal\\:\\ 0\\.02409179877979369\ \(0\)\
\-\ always\\:\\ 0\\.02402556183699399\ \(0\)\
\-\ angiography\\:\\ 0\\.02346300462796425\ \(0\)\
\-\ 32\\:\\ 0\\.023287658646808512\ \(0\)\
\-\ options\\:\\ 0\\.02268895808663624\ \(0\)\
\-\ unusual\\:\\ 0\\.02258681528329114\ \(0\)\
\-\ medicine\\:\\ 0\\.022149423438080556\ \(0\)\
\-\ injection\\:\\ 0\\.021788003752263373\ \(0\)\
\-\ radiotracer\\:\\ 0\\.021788003752263373\ \(0\)\
\-\ thought\\:\\ 0\\.021490254105902336\ \(0\)\
\-\ focus\\:\\ 0\\.020976965472928544\ \(0\)\
\-\ difficult\\:\\ 0\\.02043904157777416\ \(0\)\
\-\ last\\:\\ 0\\.01994935765050811\ \(0\)\
\-\ \\)\\:\\ 0\\.019495565358287024\ \(0\)\
\-\ increasing\\:\\ 0\\.019138319371173284\ \(0\)\
\-\ includes\\:\\ 0\\.018824483037370686\ \(0\)\
\-\ additional\\:\\ 0\\.018723752427049167\ \(0\)\
\-\ diagnostic\\:\\ 0\\.01850367647547572\ \(0\)\
\-\ also\\:\\ 0\\.018411143100220233\ \(0\)\
\-\ based\\:\\ 0\\.017807051159928745\ \(0\)\
\-\ activity\\:\\ 0\\.01751938048514502\ \(0\)\
\-\ which\\:\\ 0\\.017433274177514193\ \(0\)\
\-\ weakness\\:\\ 0\\.017342138541138714\ \(0\)\
\-\ could\\:\\ 0\\.01722709258923799\ \(0\)\
\-\ first\\:\\ 0\\.015669308386807936\ \(0\)\
\-\ differential\\:\\ 0\\.014824917100289232\ \(0\)\
\-\ bowel\\:\\ 0\\.014644554824506882\ \(0\)\
\-\ medical\\:\\ 0\\.014367813115114777\ \(0\)\
\-\ only\\:\\ 0\\.014040500866037899\ \(0\)\
\-\ evaluation\\:\\ 0\\.013564146425283103\ \(0\)\
\-\ time\\:\\ 0\\.013189077744477118\ \(0\)\
\-\ y\\/o\\:\\ 0\\.012932399070052681\ \(0\)\
\-\ if\\:\\ 0\\.01267072914634227\ \(0\)\
\-\ at\\:\\ 0\\.012653149211274677\ \(0\)\
\-\ therapy\\:\\ 0\\.012484375935741055\ \(0\)\
\-\ patients\\:\\ 0\\.012085107100360797\ \(0\)\
\-\ surgery\\:\\ 0\\.011338792701422268\ \(0\)\
\-\ 1\\:\\ 0\\.011111073048960148\ \(0\)\
\-\ 3\\:\\ 0\\.01093429249566415\ \(0\)\
\-\ was\\:\\ 0\\.010800847237308052\ \(0\)\
\-\ diagnosis\\:\\ 0\\.01072251000426459\ \(0\)\
\-\ \\'s\\:\\ 0\\.010295336712388223\ \(0\)\
\-\ case\\:\\ 0\\.010215871217853938\ \(0\)\
\-\ 2\\:\\ 0\\.010055215827926482\ \(0\)\
\-\ but\\:\\ 0\\.009959034431877255\ \(0\)\
\-\ treatment\\:\\ 0\\.009451458795633262\ \(0\)\
\-\ male\\:\\ 0\\.008443746108674717\ \(0\)\
\-\ that\\:\\ 0\\.008065468462070072\ \(0\)\
\-\ \\(\\:\\ 0\\.00789466367479629\ \(0\)\
\-\ disease\\:\\ 0\\.007632445580413684\ \(0\)\
\-\ \\,\\:\\ 0\\.007396449877521513\ \(0\)\
\-\ not\\:\\ 0\\.006747643014983254\ \(0\)\
\-\ or\\:\\ 0\\.005472801906905506\ \(0\)\
\-\ this\\:\\ 0\\.005252115919749361\ \(0\)\
\-\ and\\:\\ 0\\.004918278845142581\ \(0\)\
\-\ patient\\:\\ 0\\.00468083022358682\ \(0\)\
\-\ to\\:\\ 0\\.004667411021234823\ \(0\)\
\-\ in\\:\\ 0\\.004605434209183114\ \(0\)\
\-\ for\\:\\ 0\\.003984197533566749\ \(0\)\
\-\ on\\:\\ 0\\.003955688592160809\ \(0\)\
\-\ is\\:\\ 0\\.003072627204288118\ \(0\)\
\-\ \\.\\:\\ 0\\.0019398653605107253\ \(0\)\
\-\ of\\:\\ 0\\.0019098983737375153\ \(0\)\
\-\ the\\:\\ 0\\.0015109211443019212\ \(0\)\
\-\ with\\:\\ 0\\.0006393670824584139\ \(0\)\
